Get the Stockscreener App
7.99
1.36%
-0.11
Journey Medical Corp stock is traded at $7.99, with a volume of 94,712.
It is down -1.36% in the last 24 hours and up +9.90% over the past month.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
See More
Previous Close:
$8.10
Open:
$8.14
24h Volume:
94,712
Relative Volume:
0.60
Market Cap:
$265.72M
Revenue:
$56.13M
Net Income/Loss:
$-14.67M
P/E Ratio:
-10.80
EPS:
-0.74
Net Cash Flow:
$-9.13M
1W Performance:
-5.11%
1M Performance:
+9.90%
6M Performance:
+1.52%
1Y Performance:
+56.97%
1-Day Range:
$7.92
$8.2859
1-Week Range:
$7.5003
$8.5849
52-Week Range:
$4.85
$9.555
Journey Medical Corp Stock (DERM) Company Profile
Name
Journey Medical Corp
Sector
Phone
480-434-6670
Address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.99 | 269.38M | 56.13M | -14.67M | -9.13M | -0.74 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | H.C. Wainwright | Buy |
| Jul-30-25 | Resumed | B. Riley Securities | Buy |
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-28-24 | Resumed | ROTH MKM | Buy |
| Dec-07-21 | Initiated | B. Riley Securities | Buy |
Journey Medical Corp Stock (DERM) Latest News
Buyout Rumor: Can Journey Medical Corporation be recession proofJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - baoquankhu1.vn
Insurer Seeks To Cap Coverage In $3M Medical Transport Row - Law360
Essex Investment Management Co. LLC Acquires 125,818 Shares of Journey Medical Corporation $DERM - MarketBeat
Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica - GlobeNewswire Inc.
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Journey Medical (NASDAQ:DERM) Shares Down 3.7%Here's What Happened - MarketBeat
Patient journey goes digital at Ewha Womans Seoul Hospital - Healthcare IT News
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target By Investing.com - Investing.com South Africa
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target - Investing.com
10 Best Travel Insurance Companies For 2026 - Forbes
Will Journey Medical Corporation benefit from geopolitical trendsPortfolio Update Summary & Growth Oriented Trading Recommendations - mfd.ru
Value Recap: Can Journey Medical Corporation reach all time highs this year - baoquankhu1.vn
Risk Analysis: Is DUKPRA impacted by rising ratesMarket Risk Report & Community Supported Trade Ideas - baoquankhu1.vn
CVS Health Corp.: How a Pharmacy Giant Is Rebooting Itself as a Healthcare Platform - AD HOC NEWS
Journey Medical Corp entered into sales agreement to offer and sell up to 3.75 million shares of common stock - marketscreener.com
Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock - TradingView
Published on: 2026-01-20 22:55:08 - baoquankhu1.vn
Does Autonomix Medical Inc meet Warren Buffetts criteriaJuly 2025 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Published on: 2026-01-19 20:20:55 - baoquankhu1.vn
Journey Medical Corp: Small-Cap Dermatology Stock Walks a Tightrope Between Turnaround Hopes and Vol - AD HOC NEWS
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of “Hold” by Analysts - Defense World
Journey Medical Files $150 Million Mixed Shelf - marketscreener.com
Journey Medical (NASDAQ:DERM) Trading 3.4% HigherHere's What Happened - MarketBeat
WebMD Launches Embody -- A Whole-Self Health, Weight Loss, and Weight Management Platform - The AI Journal
Early ZYCUBO treatment cut death risk nearly 80% in children with Menkes - Stock Titan
CVS Health Corp.: How a Pharmacy Giant Is Re?Engineering the Front Door to U.S. Healthcare - AD HOC NEWS
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data - MSN
Will Journey Medical Corporation stock gain from government policiesJuly 2025 Retail & AI Enhanced Trading Signals - Улправда
Is Microbot Medical Inc. (CY9D) stock vulnerable to rate hikesWeekly Stock Report & Weekly High Return Opportunities - ulpravda.ru
Can Tenon Medical Inc. Equity Warrant stock hit record highs againJuly 2025 Retail & Weekly Hot Stock Watchlists - Улправда
Why Orthofix Medical Inc. (OM2) stock is upgraded to buyAnalyst Upgrade & Safe Capital Growth Tips - Улправда
IMG Opens Applications for 2026 Spring Semester 'Student Journey Scholarship' - Yahoo Finance
Best Medical Travel Insurance Companies of 2026 - U.S. News & World Report
9 Best Performing Micro Cap Stocks in 2025 - Insider Monkey
Trending At The PTAB: The Journey Of IPR Institution In 2025 - Law360
The Truth About Journey Medical Corp (DERM): Tiny Stock, Big Drama – Is It Worth the Hype? - AD HOC NEWS
Layoff Tracker: Nido Will Close Following Lead Candidate’s Disappointing Phase II Results - BioSpace
Fourteen new option listings on November 12th - MSN
Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33% - Yahoo Finance
Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Earnings Beat: Why Profound Medical Corp stock attracts high net worth investorsMarket Trend Review & Risk Controlled Swing Trade Alerts - moha.gov.vn
Aug Weekly: Can Quipt Home Medical Corp. stock reach $100 price targetPortfolio Return Report & Reliable Entry Point Alerts - ulpravda.ru
Journey Medical (NASDAQ:DERM) Trading 2.1% Higher – What’s Next? - Defense World
How Orthofix Medical Inc. stock performs in interest rate cycles2025 Volatility Report & Accurate Entry and Exit Point Alerts - ulpravda.ru
Sheets Smith Investment Management Invests $946,000 in Journey Medical Corporation $DERM - MarketBeat
Is Journey Medical Corporation stock cheap at current valuationWeekly Trade Review & Target Return Focused Stock Picks - Улправда
Journey Medical (NASDAQ:DERM) Trading 2.1% HigherWhat's Next? - MarketBeat
How Journey Medical Corporation stock benefits from tech adoptionWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Journey Medical Corp Stock (DERM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):